

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sodium ion export (GO:0071436) | 4.23957509 |
| 2 | response to pheromone (GO:0019236) | 4.04000789 |
| 3 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.97969583 |
| 4 | cell communication by electrical coupling (GO:0010644) | 3.80752220 |
| 5 | cellular potassium ion homeostasis (GO:0030007) | 3.34848051 |
| 6 | activation of protein kinase A activity (GO:0034199) | 3.33059545 |
| 7 | desmosome organization (GO:0002934) | 3.31388285 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.19296881 |
| 9 | carnitine shuttle (GO:0006853) | 3.18859039 |
| 10 | NADH metabolic process (GO:0006734) | 3.15694306 |
| 11 | cell communication involved in cardiac conduction (GO:0086065) | 3.11980261 |
| 12 | lysine catabolic process (GO:0006554) | 3.11566929 |
| 13 | lysine metabolic process (GO:0006553) | 3.11566929 |
| 14 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.03636324 |
| 15 | fatty acid transmembrane transport (GO:1902001) | 3.03502476 |
| 16 | 2-oxoglutarate metabolic process (GO:0006103) | 3.03117359 |
| 17 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.02675882 |
| 18 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.02623013 |
| 19 | plasma membrane repair (GO:0001778) | 2.98359481 |
| 20 | protein localization to endosome (GO:0036010) | 2.97858377 |
| 21 | synaptic vesicle maturation (GO:0016188) | 2.96558433 |
| 22 | adhesion of symbiont to host (GO:0044406) | 2.93296654 |
| 23 | adhesion of symbiont to host cell (GO:0044650) | 2.92777705 |
| 24 | virion attachment to host cell (GO:0019062) | 2.92777705 |
| 25 | tricarboxylic acid cycle (GO:0006099) | 2.92559154 |
| 26 | layer formation in cerebral cortex (GO:0021819) | 2.92253606 |
| 27 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.91665683 |
| 28 | COPI coating of Golgi vesicle (GO:0048205) | 2.86910085 |
| 29 | Golgi transport vesicle coating (GO:0048200) | 2.86910085 |
| 30 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.85604638 |
| 31 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.84730651 |
| 32 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.82743046 |
| 33 | locomotory exploration behavior (GO:0035641) | 2.82149580 |
| 34 | potassium ion import (GO:0010107) | 2.80897758 |
| 35 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.77966380 |
| 36 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.77078398 |
| 37 | regulation of synapse structural plasticity (GO:0051823) | 2.73087105 |
| 38 | synaptic vesicle exocytosis (GO:0016079) | 2.68423443 |
| 39 | macroautophagy (GO:0016236) | 2.65217687 |
| 40 | tricarboxylic acid metabolic process (GO:0072350) | 2.64223137 |
| 41 | regulation of fatty acid oxidation (GO:0046320) | 2.62647670 |
| 42 | endothelial cell chemotaxis (GO:0035767) | 2.60101248 |
| 43 | succinate metabolic process (GO:0006105) | 2.59737718 |
| 44 | regulation of plasminogen activation (GO:0010755) | 2.59374273 |
| 45 | oxaloacetate metabolic process (GO:0006107) | 2.57308645 |
| 46 | carnitine transmembrane transport (GO:1902603) | 2.56659438 |
| 47 | regulation of extracellular matrix disassembly (GO:0010715) | 2.56650124 |
| 48 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.56552666 |
| 49 | hemidesmosome assembly (GO:0031581) | 2.55646304 |
| 50 | cerebellar Purkinje cell layer development (GO:0021680) | 2.53897617 |
| 51 | positive regulation of synapse maturation (GO:0090129) | 2.53559071 |
| 52 | neuromuscular process controlling posture (GO:0050884) | 2.52852218 |
| 53 | aspartate family amino acid catabolic process (GO:0009068) | 2.52303146 |
| 54 | cardiac muscle contraction (GO:0060048) | 2.51843994 |
| 55 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.51774336 |
| 56 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.51189555 |
| 57 | regulation of vitamin metabolic process (GO:0030656) | 2.50922231 |
| 58 | sarcomere organization (GO:0045214) | 2.50433500 |
| 59 | regulation of ARF protein signal transduction (GO:0032012) | 2.50260993 |
| 60 | carnitine transport (GO:0015879) | 2.48655954 |
| 61 | amino-acid betaine transport (GO:0015838) | 2.48655954 |
| 62 | alpha-linolenic acid metabolic process (GO:0036109) | 2.48560592 |
| 63 | vocalization behavior (GO:0071625) | 2.47895011 |
| 64 | alanine transport (GO:0032328) | 2.45544221 |
| 65 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.45470458 |
| 66 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.44927196 |
| 67 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.43129278 |
| 68 | cardiac myofibril assembly (GO:0055003) | 2.43062404 |
| 69 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.42370048 |
| 70 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.42362604 |
| 71 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.42362604 |
| 72 | cellular sodium ion homeostasis (GO:0006883) | 2.42044186 |
| 73 | mannose metabolic process (GO:0006013) | 2.41343453 |
| 74 | cellular ketone body metabolic process (GO:0046950) | 2.41337150 |
| 75 | regulation of cholesterol metabolic process (GO:0090181) | 2.41055502 |
| 76 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.40733586 |
| 77 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.40003171 |
| 78 | potassium ion homeostasis (GO:0055075) | 2.36170070 |
| 79 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.35914436 |
| 80 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.34358234 |
| 81 | detection of calcium ion (GO:0005513) | 2.33273810 |
| 82 | creatine metabolic process (GO:0006600) | 2.32931812 |
| 83 | neurotransmitter secretion (GO:0007269) | 2.32635567 |
| 84 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.32539940 |
| 85 | regulation of membrane repolarization (GO:0060306) | 2.32065931 |
| 86 | endocytic recycling (GO:0032456) | 2.31472389 |
| 87 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.31242499 |
| 88 | protein retention in ER lumen (GO:0006621) | 2.30507728 |
| 89 | regulation of cholesterol homeostasis (GO:2000188) | 2.30057470 |
| 90 | negative regulation of cell size (GO:0045792) | 2.29948834 |
| 91 | fatty acid beta-oxidation (GO:0006635) | 2.29875877 |
| 92 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.29386316 |
| 93 | COPII vesicle coating (GO:0048208) | 2.29245042 |
| 94 | sulfur amino acid catabolic process (GO:0000098) | 2.29063515 |
| 95 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.29008134 |
| 96 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.28497864 |
| 97 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.28279247 |
| 98 | low-density lipoprotein particle clearance (GO:0034383) | 2.27401890 |
| 99 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.26981993 |
| 100 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.26849492 |
| 101 | glomerular basement membrane development (GO:0032836) | 2.26289826 |
| 102 | glutamate secretion (GO:0014047) | 2.25751660 |
| 103 | activation of MAPKKK activity (GO:0000185) | 2.25695925 |
| 104 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.24910735 |
| 105 | proline transport (GO:0015824) | 2.24184150 |
| 106 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.23685118 |
| 107 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.22702112 |
| 108 | regulation of synaptic vesicle transport (GO:1902803) | 2.22332121 |
| 109 | positive regulation of fatty acid oxidation (GO:0046321) | 2.22027708 |
| 110 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.21204628 |
| 111 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.21067832 |
| 112 | positive regulation of sodium ion transport (GO:0010765) | 2.20832498 |
| 113 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.20096698 |
| 114 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.20022104 |
| 115 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.19228919 |
| 116 | glycosphingolipid catabolic process (GO:0046479) | 2.19223159 |
| 117 | growth hormone secretion (GO:0030252) | 2.19127096 |
| 118 | glycogen catabolic process (GO:0005980) | 2.18355320 |
| 119 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.18266296 |
| 120 | neuronal ion channel clustering (GO:0045161) | 2.18158880 |
| 121 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.17577538 |
| 122 | cell migration involved in heart development (GO:0060973) | 2.16940589 |
| 123 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.16461499 |
| 124 | glucan catabolic process (GO:0009251) | 2.16342288 |
| 125 | protein localization to synapse (GO:0035418) | 2.16148160 |
| 126 | fatty acid catabolic process (GO:0009062) | 2.15822357 |
| 127 | cell volume homeostasis (GO:0006884) | 2.15487869 |
| 128 | short-chain fatty acid metabolic process (GO:0046459) | 2.15443051 |
| 129 | adherens junction assembly (GO:0034333) | 2.14737988 |
| 130 | response to inactivity (GO:0014854) | 2.14728563 |
| 131 | regulation of actin filament-based movement (GO:1903115) | 2.14188349 |
| 132 | cell-substrate junction assembly (GO:0007044) | 2.13272285 |
| 133 | epithelial cell-cell adhesion (GO:0090136) | 2.12009755 |
| 134 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.11772357 |
| 135 | regulation of p38MAPK cascade (GO:1900744) | 2.11358152 |
| 136 | fructose metabolic process (GO:0006000) | 2.11143076 |
| 137 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.11125663 |
| 138 | epoxygenase P450 pathway (GO:0019373) | 2.10707850 |
| 139 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.09679684 |
| 140 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.08977882 |
| 141 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.08023014 |
| 142 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.07830819 |
| 143 | cell-substrate adherens junction assembly (GO:0007045) | 2.07607385 |
| 144 | focal adhesion assembly (GO:0048041) | 2.07607385 |
| 145 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.07309278 |
| 146 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.07108609 |
| 147 | glycolipid catabolic process (GO:0019377) | 2.06662876 |
| 148 | negative regulation of fatty acid transport (GO:2000192) | 2.05142204 |
| 149 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.03343023 |
| 150 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.03343023 |
| 151 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.02039924 |
| 152 | receptor recycling (GO:0001881) | 1.97235802 |
| 153 | semaphorin-plexin signaling pathway (GO:0071526) | 1.94532485 |
| 154 | positive regulation of protein dephosphorylation (GO:0035307) | 1.93855272 |
| 155 | activation of Rac GTPase activity (GO:0032863) | 1.93466825 |
| 156 | regulation of extracellular matrix organization (GO:1903053) | 1.93306178 |
| 157 | angiotensin maturation (GO:0002003) | 1.92181695 |
| 158 | diaphragm development (GO:0060539) | 1.92095406 |
| 159 | glucose 6-phosphate metabolic process (GO:0051156) | 1.91895514 |
| 160 | cell-cell junction maintenance (GO:0045217) | 1.91849799 |
| 161 | endoplasmic reticulum unfolded protein response (GO:0030968) | 1.91624209 |
| 162 | sphingolipid catabolic process (GO:0030149) | 1.91415661 |
| 163 | myelin maintenance (GO:0043217) | 1.91307444 |
| 164 | membrane lipid catabolic process (GO:0046466) | 1.90048604 |
| 165 | regulation of cholesterol storage (GO:0010885) | 1.90012847 |
| 166 | negative regulation of catenin import into nucleus (GO:0035414) | 1.89282992 |
| 167 | positive regulation of steroid biosynthetic process (GO:0010893) | 1.88122200 |
| 168 | response to magnesium ion (GO:0032026) | 1.87972971 |
| 169 | urea cycle (GO:0000050) | 1.87287471 |
| 170 | endoplasmic reticulum organization (GO:0007029) | 1.87280056 |
| 171 | 4-hydroxyproline metabolic process (GO:0019471) | 1.87239189 |
| 172 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 1.86065762 |
| 173 | cell adhesion mediated by integrin (GO:0033627) | 1.85871171 |
| 174 | vesicle coating (GO:0006901) | 1.84824946 |
| 175 | endocardial cushion development (GO:0003197) | 1.84481820 |
| 176 | urea metabolic process (GO:0019627) | 1.82798161 |
| 177 | dopamine receptor signaling pathway (GO:0007212) | 1.82715554 |
| 178 | positive regulation of nuclease activity (GO:0032075) | 1.82662129 |
| 179 | glutathione biosynthetic process (GO:0006750) | 1.82449879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.39455752 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.30955603 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.29951741 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.79636403 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.45049043 |
| 6 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.30028510 |
| 7 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.23601566 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.08034644 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.07556885 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.07148880 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.05956194 |
| 12 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.97053670 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.95984365 |
| 14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.93646388 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.92425120 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.89656508 |
| 17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.89451110 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.84880551 |
| 19 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.84858758 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.83493031 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.81153972 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78622338 |
| 23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.76610924 |
| 24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.75954263 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74521283 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.73965017 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.67473246 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.67473246 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.66619338 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.66324310 |
| 31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.66269831 |
| 32 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63851881 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63324294 |
| 34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.63176366 |
| 35 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.62362510 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.61628971 |
| 37 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.61022750 |
| 38 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.58669713 |
| 39 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56848267 |
| 40 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.56519815 |
| 41 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.53554285 |
| 42 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.51659741 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49809071 |
| 44 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.48903735 |
| 45 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.44860791 |
| 46 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.44828299 |
| 47 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.44350106 |
| 48 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.42730519 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39796433 |
| 50 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.36934471 |
| 51 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33780126 |
| 52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33126411 |
| 53 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.32452453 |
| 54 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.31783880 |
| 55 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.31248144 |
| 56 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.30186233 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29981298 |
| 58 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.29925725 |
| 59 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29607770 |
| 60 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.28637265 |
| 61 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.27960716 |
| 62 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.25969200 |
| 63 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.25604406 |
| 64 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23543344 |
| 65 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20945317 |
| 66 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.20578736 |
| 67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20577264 |
| 68 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17095335 |
| 69 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17090410 |
| 70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17036614 |
| 71 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16910613 |
| 72 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16496597 |
| 73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16224414 |
| 74 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15893024 |
| 75 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15893024 |
| 76 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15888468 |
| 77 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15800331 |
| 78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15558878 |
| 79 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15508311 |
| 80 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.15422313 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14614266 |
| 82 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.14551871 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14218733 |
| 84 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.13943331 |
| 85 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.11525810 |
| 86 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.08337733 |
| 87 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.08110897 |
| 88 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06772084 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05086088 |
| 90 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04218861 |
| 91 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03832905 |
| 92 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03832905 |
| 93 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02660738 |
| 94 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02460830 |
| 95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02189814 |
| 96 | ATF3_27146783_Chip-Seq_COLON_Human | 1.01766487 |
| 97 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.01531218 |
| 98 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01257872 |
| 99 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01237096 |
| 100 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00464397 |
| 101 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.00404221 |
| 102 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.00283918 |
| 103 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.00236090 |
| 104 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99106208 |
| 105 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99073926 |
| 106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98489841 |
| 107 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.98207824 |
| 108 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.97591363 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97517729 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96798023 |
| 111 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96775750 |
| 112 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.96712155 |
| 113 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.96598450 |
| 114 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96223290 |
| 115 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.96066515 |
| 116 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.95929148 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95485436 |
| 118 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95434842 |
| 119 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.94055779 |
| 120 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93776825 |
| 121 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93708589 |
| 122 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92896195 |
| 123 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92766740 |
| 124 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.92606300 |
| 125 | P68_20966046_ChIP-Seq_HELA_Human | 0.92471887 |
| 126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91596649 |
| 127 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91530977 |
| 128 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.91350301 |
| 129 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90600574 |
| 130 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89394990 |
| 131 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89142875 |
| 132 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.88784074 |
| 133 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86508954 |
| 134 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86268751 |
| 135 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86210014 |
| 136 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.81591302 |
| 137 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.81160133 |
| 138 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.80701648 |
| 139 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.80180631 |
| 140 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.79578622 |
| 141 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78917063 |
| 142 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78622792 |
| 143 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.76922851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.75700239 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.56614538 |
| 3 | MP0005058_abnormal_lysosome_morphology | 2.97258141 |
| 4 | MP0000751_myopathy | 2.94930708 |
| 5 | MP0005451_abnormal_body_composition | 2.65065353 |
| 6 | MP0005360_urolithiasis | 2.56069139 |
| 7 | MP0002909_abnormal_adrenal_gland | 2.55522615 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 2.47455883 |
| 9 | MP0004130_abnormal_muscle_cell | 2.45646724 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.31385686 |
| 11 | MP0004270_analgesia | 2.21013946 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.10108208 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.09609487 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.07865763 |
| 15 | MP0004215_abnormal_myocardial_fiber | 2.05354095 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 2.04813986 |
| 17 | MP0004036_abnormal_muscle_relaxation | 2.03887131 |
| 18 | MP0003329_amyloid_beta_deposits | 2.02615968 |
| 19 | MP0009840_abnormal_foam_cell | 2.00666113 |
| 20 | MP0000013_abnormal_adipose_tissue | 1.89987769 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 1.85322818 |
| 22 | MP0003646_muscle_fatigue | 1.81407374 |
| 23 | MP0005330_cardiomyopathy | 1.80362963 |
| 24 | MP0004145_abnormal_muscle_electrophysio | 1.79851186 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.78479714 |
| 26 | MP0002822_catalepsy | 1.76067747 |
| 27 | MP0005365_abnormal_bile_salt | 1.75500350 |
| 28 | MP0000749_muscle_degeneration | 1.75372862 |
| 29 | MP0000747_muscle_weakness | 1.73478057 |
| 30 | MP0002332_abnormal_exercise_endurance | 1.72158051 |
| 31 | MP0005670_abnormal_white_adipose | 1.70466117 |
| 32 | MP0010329_abnormal_lipoprotein_level | 1.66334160 |
| 33 | MP0002063_abnormal_learning/memory/cond | 1.60910444 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.60650048 |
| 35 | MP0008961_abnormal_basal_metabolism | 1.59645750 |
| 36 | MP0002064_seizures | 1.50902624 |
| 37 | MP0009745_abnormal_behavioral_response | 1.48065345 |
| 38 | MP0009046_muscle_twitch | 1.46508643 |
| 39 | MP0003252_abnormal_bile_duct | 1.46207855 |
| 40 | MP0001849_ear_inflammation | 1.45472930 |
| 41 | MP0003137_abnormal_impulse_conducting | 1.45303450 |
| 42 | MP0004087_abnormal_muscle_fiber | 1.44822505 |
| 43 | MP0005535_abnormal_body_temperature | 1.42215823 |
| 44 | MP0008875_abnormal_xenobiotic_pharmacok | 1.40503287 |
| 45 | MP0005666_abnormal_adipose_tissue | 1.38956725 |
| 46 | MP0003195_calcinosis | 1.36558548 |
| 47 | MP0003091_abnormal_cell_migration | 1.34449350 |
| 48 | MP0000604_amyloidosis | 1.31752003 |
| 49 | MP0003880_abnormal_central_pattern | 1.31550234 |
| 50 | MP0002269_muscular_atrophy | 1.29843713 |
| 51 | MP0005620_abnormal_muscle_contractility | 1.29479283 |
| 52 | MP0001501_abnormal_sleep_pattern | 1.26250381 |
| 53 | MP0004510_myositis | 1.24784798 |
| 54 | MP0002972_abnormal_cardiac_muscle | 1.24637410 |
| 55 | MP0002896_abnormal_bone_mineralization | 1.24414120 |
| 56 | MP0002078_abnormal_glucose_homeostasis | 1.23309477 |
| 57 | MP0002118_abnormal_lipid_homeostasis | 1.22453457 |
| 58 | MP0001661_extended_life_span | 1.21339885 |
| 59 | MP0003879_abnormal_hair_cell | 1.21199939 |
| 60 | MP0002234_abnormal_pharynx_morphology | 1.19899651 |
| 61 | MP0005375_adipose_tissue_phenotype | 1.19020078 |
| 62 | MP0005332_abnormal_amino_acid | 1.18831119 |
| 63 | MP0004085_abnormal_heartbeat | 1.18593261 |
| 64 | MP0005257_abnormal_intraocular_pressure | 1.17674575 |
| 65 | MP0004043_abnormal_pH_regulation | 1.17080827 |
| 66 | MP0001348_abnormal_lacrimal_gland | 1.16792084 |
| 67 | MP0002272_abnormal_nervous_system | 1.16082795 |
| 68 | MP0002733_abnormal_thermal_nociception | 1.15900524 |
| 69 | MP0008569_lethality_at_weaning | 1.15802165 |
| 70 | MP0003300_gastrointestinal_ulcer | 1.15793363 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 1.14562516 |
| 72 | MP0008775_abnormal_heart_ventricle | 1.12793445 |
| 73 | MP0004858_abnormal_nervous_system | 1.12613309 |
| 74 | MP0005023_abnormal_wound_healing | 1.11911399 |
| 75 | MP0005595_abnormal_vascular_smooth | 1.11683063 |
| 76 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.11649683 |
| 77 | MP0009384_cardiac_valve_regurgitation | 1.10760760 |
| 78 | MP0002971_abnormal_brown_adipose | 1.10548827 |
| 79 | MP0008260_abnormal_autophagy | 1.10101854 |
| 80 | MP0000003_abnormal_adipose_tissue | 1.07311289 |
| 81 | MP0003633_abnormal_nervous_system | 1.06702776 |
| 82 | MP0003634_abnormal_glial_cell | 1.06261858 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 1.06193008 |
| 84 | MP0002572_abnormal_emotion/affect_behav | 1.05581324 |
| 85 | MP0002106_abnormal_muscle_physiology | 1.05191812 |
| 86 | MP0000759_abnormal_skeletal_muscle | 1.04761314 |
| 87 | MP0006138_congestive_heart_failure | 1.04360822 |
| 88 | MP0005083_abnormal_biliary_tract | 1.04347618 |
| 89 | MP0002060_abnormal_skin_morphology | 1.04067765 |
| 90 | MP0001544_abnormal_cardiovascular_syste | 1.03739814 |
| 91 | MP0005385_cardiovascular_system_phenoty | 1.03739814 |
| 92 | MP0001440_abnormal_grooming_behavior | 1.02636758 |
| 93 | MP0005166_decreased_susceptibility_to | 1.02037226 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 1.02028962 |
| 95 | MP0004233_abnormal_muscle_weight | 1.01548563 |
| 96 | MP0000733_abnormal_muscle_development | 1.01492138 |
| 97 | MP0003183_abnormal_peptide_metabolism | 1.01426761 |
| 98 | MP0001664_abnormal_digestion | 1.00529498 |
| 99 | MP0002734_abnormal_mechanical_nocicepti | 0.99729923 |
| 100 | MP0001502_abnormal_circadian_rhythm | 0.99723764 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.99534289 |
| 102 | MP0001958_emphysema | 0.99106526 |
| 103 | MP0001970_abnormal_pain_threshold | 0.98865145 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.98304014 |
| 105 | MP0004185_abnormal_adipocyte_glucose | 0.97787156 |
| 106 | MP0000230_abnormal_systemic_arterial | 0.97374052 |
| 107 | MP0009643_abnormal_urine_homeostasis | 0.97348593 |
| 108 | MP0004811_abnormal_neuron_physiology | 0.97287965 |
| 109 | MP0003075_altered_response_to | 0.96960775 |
| 110 | MP0004484_altered_response_of | 0.96748729 |
| 111 | MP0001666_abnormal_nutrient_absorption | 0.96678968 |
| 112 | MP0005409_darkened_coat_color | 0.96461229 |
| 113 | MP0005645_abnormal_hypothalamus_physiol | 0.96450366 |
| 114 | MP0006036_abnormal_mitochondrial_physio | 0.95527337 |
| 115 | MP0003191_abnormal_cellular_cholesterol | 0.93359956 |
| 116 | MP0000609_abnormal_liver_physiology | 0.92805672 |
| 117 | MP0003690_abnormal_glial_cell | 0.92639037 |
| 118 | MP0002090_abnormal_vision | 0.92391500 |
| 119 | MP0008874_decreased_physiological_sensi | 0.91232300 |
| 120 | MP0005503_abnormal_tendon_morphology | 0.90958781 |
| 121 | MP0000678_abnormal_parathyroid_gland | 0.90540629 |
| 122 | MP0001765_abnormal_ion_homeostasis | 0.90198634 |
| 123 | MP0003303_peritoneal_inflammation | 0.89754120 |
| 124 | MP0000750_abnormal_muscle_regeneration | 0.89150040 |
| 125 | MP0003705_abnormal_hypodermis_morpholog | 0.88213095 |
| 126 | MP0004947_skin_inflammation | 0.88075544 |
| 127 | MP0003279_aneurysm | 0.88032565 |
| 128 | MP0003283_abnormal_digestive_organ | 0.86681952 |
| 129 | MP0005448_abnormal_energy_balance | 0.86043569 |
| 130 | MP0001968_abnormal_touch/_nociception | 0.85571017 |
| 131 | MP0005167_abnormal_blood-brain_barrier | 0.83763511 |
| 132 | MP0000920_abnormal_myelination | 0.83355007 |
| 133 | MP0005165_increased_susceptibility_to | 0.83312756 |
| 134 | MP0005369_muscle_phenotype | 0.82995596 |
| 135 | MP0003045_fibrosis | 0.82092050 |
| 136 | MP0000467_abnormal_esophagus_morphology | 0.81464776 |
| 137 | MP0003806_abnormal_nucleotide_metabolis | 0.81255706 |
| 138 | MP0010352_gastrointestinal_tract_polyps | 0.79542548 |
| 139 | MP0002138_abnormal_hepatobiliary_system | 0.77279013 |
| 140 | MP0004019_abnormal_vitamin_homeostasis | 0.75911949 |
| 141 | MP0002108_abnormal_muscle_morphology | 0.75109901 |
| 142 | MP0002876_abnormal_thyroid_physiology | 0.74070745 |
| 143 | MP0005334_abnormal_fat_pad | 0.73132511 |
| 144 | MP0008004_abnormal_stomach_pH | 0.70588772 |
| 145 | MP0002089_abnormal_postnatal_growth/wei | 0.70535171 |
| 146 | MP0001756_abnormal_urination | 0.70135129 |
| 147 | MP0002254_reproductive_system_inflammat | 0.67792562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 3.80831128 |
| 2 | Sudden death (HP:0001699) | 3.77388154 |
| 3 | Ketoacidosis (HP:0001993) | 3.49132169 |
| 4 | Visual hallucinations (HP:0002367) | 3.31933022 |
| 5 | Myoglobinuria (HP:0002913) | 3.30646777 |
| 6 | Bundle branch block (HP:0011710) | 3.27576916 |
| 7 | Stridor (HP:0010307) | 3.06343931 |
| 8 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.95517711 |
| 9 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.95517711 |
| 10 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.95517711 |
| 11 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.89906535 |
| 12 | Mucopolysacchariduria (HP:0008155) | 2.89906535 |
| 13 | Myokymia (HP:0002411) | 2.87009532 |
| 14 | Ketosis (HP:0001946) | 2.82883204 |
| 15 | Asymmetric septal hypertrophy (HP:0001670) | 2.79699773 |
| 16 | Dysostosis multiplex (HP:0000943) | 2.78245681 |
| 17 | Focal motor seizures (HP:0011153) | 2.78083510 |
| 18 | Hyporeflexia of lower limbs (HP:0002600) | 2.76283428 |
| 19 | Hypoglycemic coma (HP:0001325) | 2.75120519 |
| 20 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.72073468 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 2.72073468 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.72073468 |
| 23 | Muscle fiber splitting (HP:0003555) | 2.72060061 |
| 24 | Distal lower limb amyotrophy (HP:0008944) | 2.69518477 |
| 25 | Syncope (HP:0001279) | 2.68630680 |
| 26 | Exercise-induced muscle cramps (HP:0003710) | 2.67360112 |
| 27 | Upper limb amyotrophy (HP:0009129) | 2.66948173 |
| 28 | Distal upper limb amyotrophy (HP:0007149) | 2.66948173 |
| 29 | Atrioventricular block (HP:0001678) | 2.65463362 |
| 30 | Ventricular fibrillation (HP:0001663) | 2.61795105 |
| 31 | Vertebral compression fractures (HP:0002953) | 2.61321659 |
| 32 | Abnormal eating behavior (HP:0100738) | 2.61079276 |
| 33 | Neurofibrillary tangles (HP:0002185) | 2.59328761 |
| 34 | Protrusio acetabuli (HP:0003179) | 2.57747275 |
| 35 | Xanthomatosis (HP:0000991) | 2.57008398 |
| 36 | Difficulty running (HP:0009046) | 2.56724775 |
| 37 | Prolonged QT interval (HP:0001657) | 2.56399954 |
| 38 | Mitral stenosis (HP:0001718) | 2.53267869 |
| 39 | J-shaped sella turcica (HP:0002680) | 2.49342853 |
| 40 | Hydroxyprolinuria (HP:0003080) | 2.48284739 |
| 41 | Abnormality of proline metabolism (HP:0010907) | 2.48284739 |
| 42 | Heart block (HP:0012722) | 2.46235419 |
| 43 | Pheochromocytoma (HP:0002666) | 2.45362032 |
| 44 | Cervical subluxation (HP:0003308) | 2.44519474 |
| 45 | Gout (HP:0001997) | 2.40862738 |
| 46 | Abnormal atrioventricular conduction (HP:0005150) | 2.39021005 |
| 47 | Ventricular arrhythmia (HP:0004308) | 2.37819753 |
| 48 | Loss of speech (HP:0002371) | 2.37531802 |
| 49 | Abnormality of the lower motor neuron (HP:0002366) | 2.36703657 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.36610624 |
| 51 | Focal seizures (HP:0007359) | 2.36217198 |
| 52 | Hand muscle atrophy (HP:0009130) | 2.33889096 |
| 53 | Thin bony cortex (HP:0002753) | 2.32566928 |
| 54 | Abnormality of the calf musculature (HP:0001430) | 2.30277531 |
| 55 | Neuroendocrine neoplasm (HP:0100634) | 2.29166612 |
| 56 | Palpitations (HP:0001962) | 2.28961999 |
| 57 | Hypoalphalipoproteinemia (HP:0003233) | 2.28249959 |
| 58 | Calf muscle hypertrophy (HP:0008981) | 2.28243044 |
| 59 | Increased variability in muscle fiber diameter (HP:0003557) | 2.26633839 |
| 60 | Difficulty climbing stairs (HP:0003551) | 2.25647275 |
| 61 | Premature rupture of membranes (HP:0001788) | 2.25633017 |
| 62 | Atrophic scars (HP:0001075) | 2.22952556 |
| 63 | Depression (HP:0000716) | 2.22823947 |
| 64 | Right ventricular cardiomyopathy (HP:0011663) | 2.22530084 |
| 65 | Skin nodule (HP:0200036) | 2.21535037 |
| 66 | EMG: myopathic abnormalities (HP:0003458) | 2.19226559 |
| 67 | Ventricular tachycardia (HP:0004756) | 2.18581079 |
| 68 | Bulbar palsy (HP:0001283) | 2.18005095 |
| 69 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.17346155 |
| 70 | Increased connective tissue (HP:0009025) | 2.17052635 |
| 71 | Broad face (HP:0000283) | 2.15977655 |
| 72 | Abnormality of the Achilles tendon (HP:0005109) | 2.14615204 |
| 73 | Ragged-red muscle fibers (HP:0003200) | 2.14201198 |
| 74 | Supranuclear gaze palsy (HP:0000605) | 2.13977487 |
| 75 | Hyperglycinuria (HP:0003108) | 2.13347942 |
| 76 | Atrial fibrillation (HP:0005110) | 2.13207235 |
| 77 | Myotonia (HP:0002486) | 2.13167921 |
| 78 | Abnormal EKG (HP:0003115) | 2.12590675 |
| 79 | Rhabdomyolysis (HP:0003201) | 2.12492538 |
| 80 | Cerebral aneurysm (HP:0004944) | 2.12295455 |
| 81 | Malnutrition (HP:0004395) | 2.10973548 |
| 82 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.09278040 |
| 83 | Achilles tendon contracture (HP:0001771) | 2.09127836 |
| 84 | Primary atrial arrhythmia (HP:0001692) | 2.08681891 |
| 85 | Hyperammonemia (HP:0001987) | 2.06760598 |
| 86 | Back pain (HP:0003418) | 2.05795098 |
| 87 | Nuclear cataract (HP:0100018) | 2.05619282 |
| 88 | Short nail (HP:0001799) | 2.04804789 |
| 89 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.04642482 |
| 90 | Spinal rigidity (HP:0003306) | 2.03807003 |
| 91 | Absence seizures (HP:0002121) | 2.03746428 |
| 92 | Dysmetric saccades (HP:0000641) | 2.03518458 |
| 93 | Obstructive sleep apnea (HP:0002870) | 2.02603234 |
| 94 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.02201099 |
| 95 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.02051732 |
| 96 | Increased cerebral lipofuscin (HP:0011813) | 2.02025470 |
| 97 | Lower limb amyotrophy (HP:0007210) | 2.01322432 |
| 98 | Anxiety (HP:0000739) | 2.01039920 |
| 99 | Deep venous thrombosis (HP:0002625) | 2.00557834 |
| 100 | Hyperlipoproteinemia (HP:0010980) | 2.00505892 |
| 101 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.00239478 |
| 102 | Hyperparathyroidism (HP:0000843) | 1.98454241 |
| 103 | Polyphagia (HP:0002591) | 1.98382478 |
| 104 | Round ear (HP:0100830) | 1.97728265 |
| 105 | Rapidly progressive (HP:0003678) | 1.97356656 |
| 106 | Distal lower limb muscle weakness (HP:0009053) | 1.97108897 |
| 107 | Fragile skin (HP:0001030) | 1.96763264 |
| 108 | Supraventricular tachycardia (HP:0004755) | 1.95362802 |
| 109 | Global brain atrophy (HP:0002283) | 1.94518490 |
| 110 | Agitation (HP:0000713) | 1.94033533 |
| 111 | Late onset (HP:0003584) | 1.93638271 |
| 112 | Supraventricular arrhythmia (HP:0005115) | 1.93067645 |
| 113 | Type 1 muscle fiber predominance (HP:0003803) | 1.91776761 |
| 114 | Ankle clonus (HP:0011448) | 1.90612082 |
| 115 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.89829987 |
| 116 | Myopathic facies (HP:0002058) | 1.89099825 |
| 117 | Cerebral inclusion bodies (HP:0100314) | 1.88638375 |
| 118 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.88293975 |
| 119 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.88255199 |
| 120 | Mesangial abnormality (HP:0001966) | 1.87441068 |
| 121 | Long toe (HP:0010511) | 1.86537508 |
| 122 | Failure to thrive in infancy (HP:0001531) | 1.85667911 |
| 123 | Insomnia (HP:0100785) | 1.85193113 |
| 124 | Generalized tonic-clonic seizures (HP:0002069) | 1.85030017 |
| 125 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.84198547 |
| 126 | Frequent falls (HP:0002359) | 1.83026400 |
| 127 | Action tremor (HP:0002345) | 1.82491217 |
| 128 | Hypercortisolism (HP:0001578) | 1.81941691 |
| 129 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.81710939 |
| 130 | Complement deficiency (HP:0004431) | 1.80962615 |
| 131 | Hyperglycemia (HP:0003074) | 1.80709595 |
| 132 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.80694976 |
| 133 | Growth hormone excess (HP:0000845) | 1.80596483 |
| 134 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.80326019 |
| 135 | Abnormal gallbladder physiology (HP:0012438) | 1.79778952 |
| 136 | Cholecystitis (HP:0001082) | 1.79778952 |
| 137 | Polycythemia (HP:0001901) | 1.79751923 |
| 138 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.79742893 |
| 139 | Lipoatrophy (HP:0100578) | 1.79019229 |
| 140 | Cerebral hemorrhage (HP:0001342) | 1.78880773 |
| 141 | Torticollis (HP:0000473) | 1.78733485 |
| 142 | Muscle stiffness (HP:0003552) | 1.77989056 |
| 143 | Axonal loss (HP:0003447) | 1.77500419 |
| 144 | Dialeptic seizures (HP:0011146) | 1.77168099 |
| 145 | Status epilepticus (HP:0002133) | 1.76870170 |
| 146 | Hyperacusis (HP:0010780) | 1.76154372 |
| 147 | Neuronal loss in central nervous system (HP:0002529) | 1.75969757 |
| 148 | Postural instability (HP:0002172) | 1.75001504 |
| 149 | Truncal ataxia (HP:0002078) | 1.74424068 |
| 150 | Abnormality of complement system (HP:0005339) | 1.73103041 |
| 151 | Abnormality of carpal bone ossification (HP:0006257) | 1.72588767 |
| 152 | Wormian bones (HP:0002645) | 1.72537265 |
| 153 | Diaphragmatic weakness (HP:0009113) | 1.72246965 |
| 154 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.71532080 |
| 155 | Onion bulb formation (HP:0003383) | 1.69886516 |
| 156 | Hemorrhage of the eye (HP:0011885) | 1.69185391 |
| 157 | Focal segmental glomerulosclerosis (HP:0000097) | 1.67837898 |
| 158 | Flat acetabular roof (HP:0003180) | 1.67318520 |
| 159 | Joint stiffness (HP:0001387) | 1.66908157 |
| 160 | Advanced eruption of teeth (HP:0006288) | 1.65889851 |
| 161 | Bradycardia (HP:0001662) | 1.65202117 |
| 162 | Apathy (HP:0000741) | 1.64835153 |
| 163 | Clonus (HP:0002169) | 1.57488649 |
| 164 | Hypoventilation (HP:0002791) | 1.57276376 |
| 165 | Generalized amyotrophy (HP:0003700) | 1.57044786 |
| 166 | Aneurysm (HP:0002617) | 1.56374536 |
| 167 | Muscle fiber inclusion bodies (HP:0100299) | 1.55679184 |
| 168 | Biconcave vertebral bodies (HP:0004586) | 1.55485375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.86258008 |
| 2 | RIPK1 | 2.94583119 |
| 3 | IRAK3 | 2.77892107 |
| 4 | EPHA2 | 2.76125720 |
| 5 | MST1R | 2.65530692 |
| 6 | PKN2 | 2.48812859 |
| 7 | PHKG2 | 2.29923905 |
| 8 | PHKG1 | 2.29923905 |
| 9 | TTN | 2.29156224 |
| 10 | EPHA3 | 2.24791595 |
| 11 | LMTK2 | 2.18964784 |
| 12 | KSR2 | 2.14781716 |
| 13 | WNK3 | 1.91769632 |
| 14 | MAP3K9 | 1.88802554 |
| 15 | MAP3K3 | 1.88802543 |
| 16 | PAK6 | 1.84038286 |
| 17 | PRKD3 | 1.82759125 |
| 18 | NTRK3 | 1.80159798 |
| 19 | MAP2K3 | 1.79335143 |
| 20 | EPHA4 | 1.73499673 |
| 21 | DAPK2 | 1.73172616 |
| 22 | INSRR | 1.70615398 |
| 23 | MET | 1.67641004 |
| 24 | CAMKK1 | 1.64080915 |
| 25 | BCKDK | 1.57114123 |
| 26 | NTRK1 | 1.52766650 |
| 27 | NEK1 | 1.49835901 |
| 28 | ERN1 | 1.47288821 |
| 29 | PIM2 | 1.46047007 |
| 30 | AKT3 | 1.43930081 |
| 31 | CAMK1D | 1.40432476 |
| 32 | PTK2 | 1.40158593 |
| 33 | MAP2K6 | 1.39821133 |
| 34 | PAK3 | 1.34356132 |
| 35 | PDK4 | 1.33700231 |
| 36 | PDK3 | 1.33700231 |
| 37 | PRPF4B | 1.29118143 |
| 38 | TESK1 | 1.27280072 |
| 39 | MINK1 | 1.27223340 |
| 40 | TAOK1 | 1.25044588 |
| 41 | PDGFRA | 1.24679330 |
| 42 | MAP3K7 | 1.24671354 |
| 43 | PRKCH | 1.24554973 |
| 44 | EEF2K | 1.23802254 |
| 45 | RIPK4 | 1.22652155 |
| 46 | MAP2K4 | 1.19806035 |
| 47 | PINK1 | 1.18533691 |
| 48 | FGFR4 | 1.15017564 |
| 49 | MAP3K4 | 1.14435601 |
| 50 | LATS2 | 1.12057441 |
| 51 | SIK1 | 1.12043484 |
| 52 | TBK1 | 1.08716590 |
| 53 | MAP3K13 | 1.08369487 |
| 54 | SMG1 | 1.05238452 |
| 55 | PDPK1 | 1.04591920 |
| 56 | RET | 1.04161502 |
| 57 | MAPKAPK3 | 1.03979256 |
| 58 | MAP3K6 | 1.00594827 |
| 59 | MAP3K1 | 1.00453426 |
| 60 | STK38 | 0.98952317 |
| 61 | PDK1 | 0.98551907 |
| 62 | CAMKK2 | 0.98009559 |
| 63 | CDK5 | 0.97902757 |
| 64 | PTK6 | 0.96054781 |
| 65 | MTOR | 0.89274045 |
| 66 | ARAF | 0.89240495 |
| 67 | FER | 0.86657699 |
| 68 | OBSCN | 0.82983141 |
| 69 | KSR1 | 0.82705935 |
| 70 | ABL2 | 0.79308933 |
| 71 | FLT3 | 0.78904567 |
| 72 | MAP3K2 | 0.77900847 |
| 73 | DAPK3 | 0.77517157 |
| 74 | PRKG2 | 0.76373011 |
| 75 | NME2 | 0.75265890 |
| 76 | JAK1 | 0.75024372 |
| 77 | MAPK11 | 0.74924069 |
| 78 | PTK2B | 0.74558605 |
| 79 | MARK2 | 0.73536583 |
| 80 | MAP2K1 | 0.72700953 |
| 81 | FES | 0.71142872 |
| 82 | MAPK12 | 0.71099086 |
| 83 | GRK5 | 0.71078124 |
| 84 | TAOK2 | 0.70097856 |
| 85 | ICK | 0.68685802 |
| 86 | PRKD1 | 0.67925895 |
| 87 | TNIK | 0.67537346 |
| 88 | MAP2K2 | 0.67237334 |
| 89 | MYLK | 0.66780706 |
| 90 | CDK12 | 0.66669540 |
| 91 | CDC42BPA | 0.66065572 |
| 92 | PDGFRB | 0.65564317 |
| 93 | PRKAA1 | 0.64987957 |
| 94 | CAMK2D | 0.64598306 |
| 95 | MARK1 | 0.62484565 |
| 96 | TRPM7 | 0.62245454 |
| 97 | SIK2 | 0.61765865 |
| 98 | RPS6KA2 | 0.61271580 |
| 99 | ERBB2 | 0.60826704 |
| 100 | DMPK | 0.59592111 |
| 101 | MAP3K11 | 0.59311746 |
| 102 | JAK2 | 0.57881325 |
| 103 | EPHB1 | 0.57066830 |
| 104 | CAMK2B | 0.56856850 |
| 105 | PRKAA2 | 0.56744749 |
| 106 | PRKCG | 0.56325614 |
| 107 | PRKD2 | 0.56287543 |
| 108 | TNK2 | 0.55808945 |
| 109 | CCNB1 | 0.54496009 |
| 110 | CAMK1 | 0.52694044 |
| 111 | CAMK1G | 0.52553983 |
| 112 | STK11 | 0.52471772 |
| 113 | TYRO3 | 0.52031445 |
| 114 | DDR2 | 0.51734090 |
| 115 | NTRK2 | 0.51681522 |
| 116 | WNK4 | 0.51351603 |
| 117 | CAMK2G | 0.49050247 |
| 118 | CAMK2A | 0.48999148 |
| 119 | PDK2 | 0.48572405 |
| 120 | MAPK7 | 0.47804343 |
| 121 | DAPK1 | 0.47360604 |
| 122 | PRKCZ | 0.47308203 |
| 123 | MUSK | 0.47159401 |
| 124 | MAP3K14 | 0.46890891 |
| 125 | ROCK1 | 0.46428456 |
| 126 | CHUK | 0.46144359 |
| 127 | SCYL2 | 0.44133309 |
| 128 | MAP3K12 | 0.44110151 |
| 129 | PAK2 | 0.44093980 |
| 130 | TGFBR2 | 0.44016952 |
| 131 | IRAK2 | 0.43427062 |
| 132 | PRKACG | 0.42744960 |
| 133 | ZAP70 | 0.42208629 |
| 134 | LIMK1 | 0.41921536 |
| 135 | SGK3 | 0.40599177 |
| 136 | CDK9 | 0.39822274 |
| 137 | PIK3CA | 0.39582440 |
| 138 | PRKCI | 0.39072988 |
| 139 | SGK223 | 0.37947316 |
| 140 | SGK494 | 0.37947316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.62423927 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.61408018 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.55078171 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.54135498 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.36601478 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.22458069 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.89802106 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.85853206 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.83797633 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.80225804 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.74114603 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 1.65190747 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 1.62414309 |
| 14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.53619325 |
| 15 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.52350197 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.47752930 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.46712826 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.46710756 |
| 19 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.43774296 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.42570879 |
| 21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.42379588 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.39699989 |
| 23 | GABAergic synapse_Homo sapiens_hsa04727 | 1.39133480 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.37913861 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 1.37859269 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36145828 |
| 27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.35850337 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.35182326 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.32789720 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.30225881 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26799981 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26443225 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.25127313 |
| 34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23494488 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21020834 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.20414901 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19726750 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19611508 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15261104 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 1.14026279 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.12891924 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11011297 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 1.10814447 |
| 44 | Long-term potentiation_Homo sapiens_hsa04720 | 1.09782877 |
| 45 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.08583063 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.07115743 |
| 47 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.04366683 |
| 48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.02988515 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.01862117 |
| 50 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.01207405 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99129626 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96739664 |
| 53 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.96236182 |
| 54 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.95666367 |
| 55 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.95614761 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92531139 |
| 57 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91621703 |
| 58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.90950191 |
| 59 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90545510 |
| 60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.90250152 |
| 61 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.90147044 |
| 62 | Gap junction_Homo sapiens_hsa04540 | 0.88969957 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.88387282 |
| 64 | Mineral absorption_Homo sapiens_hsa04978 | 0.88264015 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88178090 |
| 66 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.87896396 |
| 67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87203238 |
| 68 | Nicotine addiction_Homo sapiens_hsa05033 | 0.86337029 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86168566 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85606458 |
| 71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.84154941 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82392612 |
| 73 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82056286 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81118658 |
| 75 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.79760167 |
| 76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.79512944 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.79222366 |
| 78 | Cocaine addiction_Homo sapiens_hsa05030 | 0.77616785 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.76575330 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76373443 |
| 81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74938026 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74889837 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72956721 |
| 84 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72662163 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.71429686 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.71411916 |
| 87 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71194808 |
| 88 | Pertussis_Homo sapiens_hsa05133 | 0.69319142 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68665220 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67872258 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67792531 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66614927 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66564860 |
| 94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65373716 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62841768 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62679181 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61626737 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61565674 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60993464 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60853554 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60527267 |
| 102 | Amoebiasis_Homo sapiens_hsa05146 | 0.59960937 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59843742 |
| 104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59154768 |
| 105 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59132549 |
| 106 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.58961296 |
| 107 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58440533 |
| 108 | Taste transduction_Homo sapiens_hsa04742 | 0.58405268 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58313152 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57881928 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.55878475 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.55062966 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.54865889 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.54742481 |
| 115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53791833 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | 0.53083606 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52792125 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52640660 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50777179 |
| 120 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50757021 |
| 121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50532675 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | 0.49943732 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49177543 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49174675 |
| 125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48243602 |
| 126 | Long-term depression_Homo sapiens_hsa04730 | 0.48107478 |
| 127 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48069801 |
| 128 | Peroxisome_Homo sapiens_hsa04146 | 0.48030508 |
| 129 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47529230 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46893029 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45860232 |
| 132 | Alzheimers disease_Homo sapiens_hsa05010 | 0.43606074 |
| 133 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43235151 |
| 134 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.38726421 |
| 135 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38110395 |
| 136 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37669381 |
| 137 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36751656 |

